Results 151 to 160 of about 1,869 (168)

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

New England Journal of Medicine, 2023
exaly  

Lebrikizumab-lbkz

American Journal of Health-System Pharmacy
openaire   +2 more sources

Lebrikizumab safe in adolescents and adults with atopic dermatitis

Reactions Weekly, 2023
openaire   +1 more source

The Effects of Lebrikizumab in Patients With Mild Asthma Following Whole Lung Allergen Challenge

Clinical and Experimental Allergy, 2014
J M Harris, R W Erickson
exaly  

Dose-Ranging Study of Lebrikizumab in Asthmatic Patients Not Receiving Inhaled Steroids

Journal of Allergy and Clinical Immunology, 2013
Joseph R Arron, Philip Korenblat, Wendy S Putnam   +2 more
exaly  

The Rebirth of Lebrikizumab for Airway Disease

The Journal of Allergy and Clinical Immunology: In Practice
openaire   +2 more sources

Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis

British Journal of Dermatology, 2023
openaire   +2 more sources

75474 Lebrikizumab for Refractory Atopic Dermatitis

Journal of the American Academy of Dermatology
Natalia Chalupczak, Peter Lio
openaire   +1 more source

Successful Treatment of Bullous Pemphigoid with Lebrikizumab: A Case Report

JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Lisa Grentner, Alexandra Himmer, Bernhard Lange‐Asschenfeldt, Daniel Thon   +3 more
openaire   +2 more sources

Model-Based Clinical Pharmacology Profiling and Exposure-Response Relationships of the Efficacy and Biomarker of Lebrikizumab in Patients With Moderate-to-Severe Asthma

Pulmonary Pharmacology and Therapeutics, 2017
Kun Peng, Nathanael Dirks, Cecile T J Holweg   +2 more
exaly